眼がん患者の診断と生存に対する婚姻状態の影響:観察研究
Yu Zhou1, Yi Feng1, Min Zhang2
1Department of Ophthalmology, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, China.
Medicine
|September 3, 2025
まとめ
眼がんを患っている未婚者は 後期段階で診断され,結婚した患者と比較して 生き残る可能性が低い. この集団における結婚は,よりよい全生存率と癌特有の生存率の独立した予測因子であるようです.
科学分野:
- 眼科について
- 腫瘍学
- 社会科学
背景:
- 結婚状態は 感情的支援,意思決定,医療へのアクセスを通じて 癌の管理に影響します
- 眼がんの診断と生存に対する結婚状態の影響は十分に理解されていません.
研究 の 目的:
- 婚姻状況と眼がんの診断段階との関連を調査する.
- 眼がん患者における全生存期 (OS) と癌特異生存期 (CSS) に起する婚姻状態の影響を評価する.
主な方法:
- サーベイランス・エピデミオロジー・アンド・エンド・リザルツ (SEER) データベース (2000年−2019年) のデータを使用した.
- 診断段階の分析に多変数順位ロジスティック回帰を用いた.
- 適応性スコアマッチングとKaplan-Meier曲線を用いて生存結果を評価した.
主要な成果:
- 未婚の患者は,進行した眼がんと診断される可能性が高く (OR=1. 31,P=. 001).
- 未婚の患者は,マッチング後のOS (HR=1. 40,P<. 001) とCSS (HR=1.13,P=. 022) が著しく悪かった.
- 生存の格差は時間とともに拡大し,女性,高齢者,低リスクグループではより顕著でした.
結論:
- 眼がん患者のOSとCSSの低下を予測する独立した要因です.
- 結婚は眼がんの生存率の向上と関連しており,特に特定の人口集団ではそうである.
- この発見は,眼がんのケアと支援戦略において,婚姻状態を考慮する重要性を強調しています.
関連する概念動画
01:21Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
01:20Comparing the Survival Analysis of Two or More Groups
280
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
280
02:43Mouse Models of Cancer Study
5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K